Treatment Registry
TR-0573 ActiveRecorded September 2026

Compounded tirzepatide

Sold by AVARA Rx · every compounded tirzepatide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

Recorded initial charges

First month

$378

first month, including required fees on record. The published monthly rate excludes one-time and annual fees; introductory and conditional rates may change. Some fee details are unverified or unpublished; this sum does not establish the full amount payable.

Medication · Starting price (promo code AVARA50 applied) · recorded initial monthly payment$229
Required membership · Monthly membership$149

Added from the figures recorded below.

Price

TermPer monthCharged today
Starting price (promo code AVARA50 applied)

“Avara Rx offers compounded tirzepatide online without insurance starting at $279/month ($229 with code AVARA50)”

Per month$229Charged today$229
Starting price (no promo code)

“Starting at $279”

Per month$279Charged today$279
Price sources
Visit AVARA Rx

We earn nothing from this link. It opens AVARA Rx's website without a paid referral.

History

Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.

  • September 2026 — Entry added to the register

Sourcing and terms

StatesNot disclosed as of September 2026
PrescriberBoth
CancellationYou can always login to your avararx.com account before your products ship to change your address, method of payment or to cancel your subscription.
MembershipRequired. $149 per month. Starting at $149 *$149 for the provider consultation and follow ups only. Price of the medication(s) are charged upon consult approval. Your Medication will be shipped through NovoCare.

Not yet checked: pharmacy and consult fee.

Recorded from avararx.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0573
Medication category
compounded tirzepatide
Readings
1

Related records

Other records from AVARA Rx

All AVARA Rx programs and terms

Compounded tirzepatide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 374 records of the same molecule.

Cite this entry

Treatment Registry. (2026). AVARA Rx — compounded tirzepatide (TR-0573). Last verified September 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0573

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.